National Survey Shows Women Want New Choices In Oral Contraception—Yasmin Is A New Option (NAPSA)—More than 18 million women in this country use Most CommonSide Effects Of traceptives available today. Yet, a new national survey of U.S. Moodiness one of the more than 40 oral con- ThePill: women aged 18-45 commissioned Irritability Resource Center (NWHRC) showed that nearly half (47 percent) of women who have used birth control pills in the pastfive years were dissatisfied enough to discontinue use or switch brands. e Water retention and/or bloating by the National Women’s Health In fact, the majority of women stopped using “the Pill” or switched because of dissatisfaction with sideeffects. e Acne Breasttenderness e Headache e Nausea Bleeding/spotting @ “Nearly 700,000 unintended pregnancies occur each yearin this country because womenstop tak- tions include kidney, liver and survey show that women are dis- Yasmin, it could lead to serious heart and health problems. Women taking drugs that could increase potassium should make their health care provider aware ing their birth control pills,” said Amy R. Niles, Executive Director of the NWHRC. “The results of our satisfied with the choices currently available to them. That being the case, an oral contraceptive that makes birth control more accept- able for more womenin this country is not only important, but nec- essary progress.” Yasmin (drospirenone and ethinyl] estradiol), a new low dose, monophasic oral contraceptive, is now available by prescription for the first time to U.S. women. Yasmin was approved by the FDA on May 11. Large-scale clinical trials found that Yasmin offers excellent cycle control with a low rate of spotting and breakthrough bleed- adrenal disease. If a woman has one of these conditions and takes of this use before taking Yasmin. Yasmin also has antiandro- genic activity and works by block- ing the action of androgens at the receptorsites. Drugs that may increase serum potassium when used on a daily long-term basis to treat chronic conditions or diseases include ACE inhibitors, angiotensin-II receptor antagonists, potassium- sparing diuretics, heparin, aldos- terone antagonists and NSAIDs (i.e., daily use for arthritis). Oral contraceptives (OCs) are than 99 percent effective in pre- not appropriate for all patients, and serious as well as minor side participated in clinical studiestolerated Yasmin very well, with only six percent discontinuing use due to side effects. diseases. Women who use oral ing. Further, Yasmin proved more venting pregnancy. Women who Yasmin is the only birth control pill to contain the unique progestin, drospirenone. Drospirenone influences the water and salt bal- ance in the body. It may also increase potassium levels. Women who haveconditions that may also increase potassium should there- fore not take Yasmin. These condi- effects have been reported with the use of all OCs. OCs do not protect against HIV infection (AIDS) and other sexually transmitted contraceptives are strongly ad- vised not to smoke. If you would like to learn more about Yasmin, talk to your doctor, visit www.Yasmin.com or call the toll-free number 866-Yasmin1l (927-6461) to receive a compli- mentary, informational product brochure by mail.
